Mounjaro®
Starting from £179.99/mo
Start journey Learn moreHair thinning during Wegovy treatment is real, common, and — for most people — temporary. It is linked to the stress rapid weight loss places on the hair growth cycle, not to semaglutide directly damaging hair follicles. Understanding what drives it is the first step to managing it. These are prescription-only medicines, so any changes to treatment are always a conversation with your prescriber.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most hair loss reported during Wegovy treatment follows a pattern called telogen effluvium. Under normal circumstances roughly 10–15% of hair follicles rest in the telogen (shedding) phase at any one time. When the body experiences a significant physiological stress (including rapid caloric restriction and fast weight loss) a larger-than-usual proportion of follicles shift into that resting phase simultaneously. The result is a noticeable shed roughly 6–12 weeks later, because the hair that stopped growing then takes that long to fall out.
This is important because it means the cause is almost always the weight-loss process itself, not a toxic effect of semaglutide on your follicles. The full Wegovy side-effect profile published by the NHS lists alopecia, but the mechanism in clinical data is consistent with this diet-stress pattern. You can read about the wider evidence on the link between Wegovy and hair loss if you want the fuller picture before taking action.
Knowing this matters practically: interventions aimed at regrowth drugs (minoxidil, finasteride) address a different kind of hair loss. Spending money on them before addressing nutrition and pacing is likely to be disappointing.
Reduced appetite is precisely what Wegovy is designed to produce. The problem is that appetite suppression can make it easy to eat far too little protein, and hair follicles are almost entirely made of keratin, a protein. When total protein falls, the body prioritises vital organs and downscales hair production.
A practical target most prescribers reference is 1.2–1.6 g of protein per kilogram of body weight daily. For a 90 kg adult that is roughly 108–144 g of protein, which takes deliberate planning when hunger is low. Eggs, Greek yoghurt, cottage cheese, lean meat, fish, tofu and pulses are all protein-dense without requiring large volumes of food.
Iron, zinc, biotin and vitamin D deficiencies can each independently cause or worsen hair thinning, and all of them can drop during rapid weight loss. A simple blood panel through your GP can identify any shortfall. There is no reliable evidence that biotin supplements prevent Wegovy-related shedding in people who are not actually deficient, so supplementing speculatively is unlikely to help and can interfere with some thyroid blood tests, worth flagging to your GP if you take it.
A useful daily cue: keep a protein-rich snack (Greek yoghurt, a boiled egg, a protein bar) in the same place as your phone charger or gym bag, so it is simply there when appetite is low.
Telogen effluvium tends to be diffuse rather than patchy, which means standard hair-care adjustments can reduce visible thinning even while regrowth is underway. Gentle, sulphate-free shampoo used two to three times a week rather than daily reduces mechanical stress on fragile emerging hairs. A wide-tooth comb on damp hair rather than a brush causes less breakage. Heat styling and tight styles (tight ponytails, braids worn constantly) add unnecessary traction to follicles that are already under strain.
There is some evidence that scalp massage (five minutes daily with gentle fingertip pressure) may support blood flow to follicles, though the data is modest. It costs nothing and the worst outcome is that it does not help. Avoid any topical product that claims to "block DHT" without a clinical evidence base; most of these work on androgenetic alopecia, a different condition entirely.
If you are finding the shed distressing, it is worth raising this with our prescribers at your next review. Sometimes a slower titration pace, or a temporary hold at a lower dose while nutrition catches up, can reduce the stress load on your follicles. That is a clinical decision, not something to self-manage by skipping injections. For women specifically, hormonal factors interact with this picture in ways that can make the pattern slightly different. Our guide on how to avoid hair loss on Wegovy brings together the practical steps you can take before shedding becomes a concern.
Most Wegovy-related shedding settles on its own within 3–6 months of the peak and does not require stopping treatment. But certain patterns deserve prompt medical attention.
See your GP if you notice patchy loss rather than diffuse thinning, this pattern suggests a different cause such as alopecia areata or scalp infection. Seek a review if the shed is still accelerating after six months on a stable dose, if you are losing eyebrows or eyelashes as well, or if hair loss is accompanied by fatigue, cold intolerance or unexplained weight fluctuation beyond what treatment would explain (thyroid function is worth checking). A blood test to rule out iron-deficiency anaemia and ferritin depletion is reasonable for anyone experiencing persistent shedding.
You can also report hair loss as a suspected side effect via the MHRA's Yellow Card scheme, this is open to patients as well as clinicians, and reports from real-world use help build the safety evidence base for medicines like semaglutide. The NHS publishes patient-level information on semaglutide including its side-effect profile, which is a useful reference to keep handy. If you are concerned about any other side effects alongside the hair changes, our page on semaglutide warnings and precautions covers the broader safety picture.
If you are thinking about starting Wegovy and want to discuss how side effects like hair thinning are managed from the outset, our prescribers go through suitability and safety as a standard part of the consultation, you can start your free consultation here.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.